Genomic and experimental evidence that ALKATI does not predict single agent sensitivity to ALK inhibitors
Summary: Genomic data can facilitate personalized treatment decisions by enabling therapeutic hypotheses in individual patients. Mutual exclusivity has been an empirically useful signal for identifying activating mutations that respond to single agent targeted therapies. However, a low mutation freq...
Guardado en:
Autores principales: | Haider Inam, Ivan Sokirniy, Yiyun Rao, Anushka Shah, Farnaz Naeemikia, Edward O'Brien, Cheng Dong, David M. McCandlish, Justin R. Pritchard |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f98a7049c703493fbae9b06d38862432 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- NPJ systems biology and applications
-
Thrombolytic Agents: Nanocarriers in Targeted Release
por: Minghua Shen, et al.
Publicado: (2021) -
Logical and experimental modeling of cytokine and eicosanoid signaling in psoriatic keratinocytes
por: Eirini Tsirvouli, et al.
Publicado: (2021) - Communications biology
-
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
por: Jonathan Li, et al.
Publicado: (2021)